Orion™
Spatial Biology at Scale
Accelerate your protein profiling with the only platform capable of delivering 20 channels per round
Advancing Precision Biology with Breakthrough Platforms
At RareCyte, we help researchers break barriers and accelerate discoveries with cutting-edge spatial biology
and liquid biopsy solutions. Our advanced platforms and expert services deliver high-resolution insights,
ultra-sensitive detection, and seamless end-to-end support—so you can get faster, more precise results.
Spatial Biology Platforms & Precision Biology Services
Spatial Biology

High-resolution insights for tissue-based discoveries
Liquid Biopsy

Non-invasive, ultra-sensitive rare cell detection
Services

Custom assay development, clinical trial testing, and more – powered by industry-leading spatial biology and liquid biopsy platforms.

Orion™: High-Plex Immunofluorescence
Orion overcomes spatial biology challenges with 20-channel multiplex imaging, flexible panel design with validated and custom antibodies, and high-throughput whole-slide scanning to accelerate large-scale, high-quality translational research enabling actionable spatial insights.
- 20 channels per round for comprehensive spatial profiling
- Flexible panel design with validated antibodies
- High-throughput for large cohort studies or multi-user settings
Orion advances multiplex immunofluorescence into a new era.
CyteFinder®: Rare Cell Detection and Retrieval
Automate high-throughput imaging and retrieve single cells or tissue micro-regions with ease. CyteFinder delivers full automation and an end-to-end workflow—from blood collection to single-cell isolation—ensuring sensitive, accurate, and reproducible results.
- Easy-to-use staining panels for identification and classification of rare cells
- Accelerated analysis and improved review concordance with advanced CTC machine learning algorithm
- Blood collection to CTC characterization tailored for high-throughput laboratories and access to a global CRO network

Dedicated Lab Services
RareCyte provides high-quality data for CTC applications and spatial biology, supporting therapy selection, disease monitoring, global research and clinical trials. Our expert team offers flexible, milestone-based support to align with your timelines and budget – so you can advance your work efficiently.
- Custom assay development
- Clinical trial testing, analysis, and reporting
- Best-in-class platforms, QMS, and CLIA laboratory
- Dedicated project team focused on Quality, Fast Turnaround Times, and Responsiveness
Conferences & Webinars
Conference:
Biomarkers & Precision Medicine UK 2025
London, England

Sept 30 - Oct 1, 2025
RareCyte Team:
Alex Darmoise,
Mickael Meyrand
Conference:
ABRF South Central Core Collective 2025
Dallas, TX

Sept 30 - Oct 2, 2025
RareCyte team:
Xiaocong Chen
Live Session:
Bridging the Discovery-to-Translational Gap in Spatial Biology

Oct 21, 2025, 9 am, PDT
Speaker:
Zhihong Chen, PhD
CTO, OCCAM Immune, at Icahn School of Medicine, Mount Sinai Hospital, New York
On Demand:
Exploring New Frontiers in Pancreatic Cancer Treatment with Spatial Biology

Available Now
Speaker:
Yana Zavros, PhD
Professor, University of Georgia School of Medicine
RareCyte in the News
Article:
Optimizing spatial proteomics for discovery and translational research

Tad George
Senior VP of Biology
RareCyte
Article:
Advanced spatial biology sheds new light on therapeutic research

Dr. Zhihong Chen
Chief Technology Officer
OCCAM Immune
Nature Oncogene publication:
Neoadjuvant botensilimab plus balstilimab response pattern investigated

Dr. Pashtoon Kasi
Weill Cornell Medicine